메뉴 건너뛰기




Volumn 29, Issue 4, 2008, Pages 358-364

Addressing steroid phobia: Improving the risk-benefit ratio with new agents

Author keywords

Asthma; Bioavailability; Childhood; Controller medications; Corticosteroids; Dose; ICS; Steroid phobia; Systemic; Treatment

Indexed keywords

ANTIASTHMATIC AGENT; CORTICOSTEROID;

EID: 50249142432     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3132     Document Type: Conference Paper
Times cited : (35)

References (52)
  • 1
    • 50249175065 scopus 로고    scopus 로고
    • NAEPP Expert Panel
    • National Asthma Education and Prevention Program, Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, August
    • National Asthma Education and Prevention Program. NAEPP Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma - Full Report 2007. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, August 2007.
    • (2007) Guidelines for the Diagnosis and Management of Asthma - Full Report 2007
  • 3
    • 33845808400 scopus 로고    scopus 로고
    • Inhaled corticosteroids in the treatment of respiratory allergy: Safety vs. efficacy
    • Rizzo MC, and Solé D. Inhaled corticosteroids in the treatment of respiratory allergy: Safety vs. efficacy. J Pediatr (Rio J) 82(suppl 5):S198-S205, 2006.
    • (2006) J Pediatr (Rio J) , vol.82 , Issue.SUPPL. 5
    • Rizzo, M.C.1    Solé, D.2
  • 4
    • 0033398683 scopus 로고    scopus 로고
    • Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness
    • Home R, and Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555-567, 1999.
    • (1999) J Psychosom Res , vol.47 , pp. 555-567
    • Home, R.1    Weinman, J.2
  • 5
    • 37349002020 scopus 로고    scopus 로고
    • Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the necessity-concerns framework
    • Clifford S, Barber N, and Home R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: Application of the necessity-concerns framework. J Psychosom Res 64:41-46, 2008.
    • (2008) J Psychosom Res , vol.64 , pp. 41-46
    • Clifford, S.1    Barber, N.2    Home, R.3
  • 6
    • 37349099759 scopus 로고    scopus 로고
    • Beliefs about medicines predict refill adherence to inhaled corticosteroids
    • Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 64:47-54, 2008.
    • (2008) J Psychosom Res , vol.64 , pp. 47-54
    • Menckeberg, T.T.1    Bouvy, M.L.2    Bracke, M.3
  • 7
    • 26444619422 scopus 로고    scopus 로고
    • Parental beliefs about medications and medication adherence among urban children with asthma
    • Conn KM, Halterman JS, Fisher SG, et al. Parental beliefs about medications and medication adherence among urban children with asthma. Ambul Pediatr 5:306-310, 2005.
    • (2005) Ambul Pediatr , vol.5 , pp. 306-310
    • Conn, K.M.1    Halterman, J.S.2    Fisher, S.G.3
  • 9
    • 34548458197 scopus 로고    scopus 로고
    • The impact of parents' medication beliefs on asthma management
    • Conn KM, Halterman JS, Lynch K, and Cabana MD. The impact of parents' medication beliefs on asthma management. Pediatrics 120:e521-e526, 2007.
    • (2007) Pediatrics , vol.120
    • Conn, K.M.1    Halterman, J.S.2    Lynch, K.3    Cabana, M.D.4
  • 10
    • 0028811651 scopus 로고
    • Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids
    • Hanania NA, Chapman KR, Sturtridge WC, et al. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 96:571-579, 1995.
    • (1995) J Allergy Clin Immunol , vol.96 , pp. 571-579
    • Hanania, N.A.1    Chapman, K.R.2    Sturtridge, W.C.3
  • 11
    • 0035960123 scopus 로고    scopus 로고
    • Effects of inhaled glucocorticoids on bone density in premenopausal women
    • Israel E, Banerjee TR, Fitzmaurice GM, et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345:941-947, 2001.
    • (2001) N Engl J Med , vol.345 , pp. 941-947
    • Israel, E.1    Banerjee, T.R.2    Fitzmaurice, G.M.3
  • 12
    • 0032808804 scopus 로고    scopus 로고
    • A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years
    • Egan JJ, Maden C, Kaira S, et al. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years. Eur Respir J 13:1267-1275, 1999.
    • (1999) Eur Respir J , vol.13 , pp. 1267-1275
    • Egan, J.J.1    Maden, C.2    Kaira, S.3
  • 13
    • 0035064750 scopus 로고    scopus 로고
    • Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticotsteroid treatment for two years
    • Tattersfield AE, Town GI, Johnell O, et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticotsteroid treatment for two years. Thorax 56:272-278, 2001.
    • (2001) Thorax , vol.56 , pp. 272-278
    • Tattersfield, A.E.1    Town, G.I.2    Johnell, O.3
  • 14
    • 0036240032 scopus 로고    scopus 로고
    • Inhaled corticosteroids and bone density of children with asthma
    • Bahceciler NN, Sezgin G, Nursoy MA, et al. Inhaled corticosteroids and bone density of children with asthma. J Asthma 39:151-157, 2002.
    • (2002) J Asthma , vol.39 , pp. 151-157
    • Bahceciler, N.N.1    Sezgin, G.2    Nursoy, M.A.3
  • 15
    • 0034642066 scopus 로고    scopus 로고
    • Long-term effects of budesonide or nedocromil in children with asthma
    • The Childhood Asthma Management Program Research Group
    • The Childhood Asthma Management Program Research Group. Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med. 343:1054-1063, 2000.
    • (2000) N Engl J Med , vol.343 , pp. 1054-1063
  • 17
    • 33745196961 scopus 로고    scopus 로고
    • Pediatric Montelukast Linear Growth Study Group. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week randomized double-blind study
    • Becker AB, Kuznetsova O, Vermeulen J, et al. Pediatric Montelukast Linear Growth Study Group. Linear growth in prepubertal asthmatic children treated with montelukast, beclomethasone, or placebo: A 56-week randomized double-blind study. Ann Allergy Asthma Immunol 96:800-807, 2006.
    • (2006) Ann Allergy Asthma Immunol , vol.96 , pp. 800-807
    • Becker, A.B.1    Kuznetsova, O.2    Vermeulen, J.3
  • 18
    • 0030725172 scopus 로고    scopus 로고
    • A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group
    • Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 337):1659-1165, 1997.
    • (1997) N Engl J Med 337) , pp. 1659-1165
    • Simons, F.E.1
  • 19
    • 38049050194 scopus 로고    scopus 로고
    • Ciclesonide Pediatric Growth Study Group. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma
    • Skoner DP, Maspero J, and Banerji, D, Ciclesonide Pediatric Growth Study Group. Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma. Pediatrics 121:e1-e14, 2008.
    • (2008) Pediatrics , vol.121
    • Skoner, D.P.1    Maspero, J.2    Banerji, D.3
  • 20
    • 20444466142 scopus 로고    scopus 로고
    • Protein binding and it's potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide
    • Rohatagi S, Luo Y, Shen L, et al. Protein binding and it's potential for eliciting minimal systemic side effects with a novel inhaled corticosteroid, ciclesonide. Am J Ther 12:201-209, 2005.
    • (2005) Am J Ther , vol.12 , pp. 201-209
    • Rohatagi, S.1    Luo, Y.2    Shen, L.3
  • 21
    • 18144383000 scopus 로고    scopus 로고
    • Short-term lower-leg growth rate and urine Cortisol excretion in children treated with ciclesonide
    • Agertoft L, and Pedersen S. Short-term lower-leg growth rate and urine Cortisol excretion in children treated with ciclesonide J Allergy Clin Immunol 115:940-945, 2005.
    • (2005) J Allergy Clin Immunol , vol.115 , pp. 940-945
    • Agertoft, L.1    Pedersen, S.2
  • 22
    • 11844302010 scopus 로고    scopus 로고
    • Effects of mometasone furoate dry powder inhaler on growth velocity and HPA axis function in children with asthma
    • Skoner DP, Dunn M, and Lee T. Effects of mometasone furoate dry powder inhaler on growth velocity and HPA axis function in children with asthma. Am J Respir Crit Care Med 167:A272, 2003.
    • (2003) Am J Respir Crit Care Med , vol.167
    • Skoner, D.P.1    Dunn, M.2    Lee, T.3
  • 23
    • 36348930183 scopus 로고    scopus 로고
    • Effects of one year of treatment with mometasone furoate metered dose inhaler (MF-MDI) on growth in children with asthma
    • 378s, Abs
    • Lemanske R, Lockey R, and Murphy K. Effects of one year of treatment with mometasone furoate metered dose inhaler (MF-MDI) on growth in children with asthma. Eur Respir J 24:378s, 2004 (Abs)
    • (2004) Eur Respir J , vol.24
    • Lemanske, R.1    Lockey, R.2    Murphy, K.3
  • 24
    • 33845216052 scopus 로고    scopus 로고
    • Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma
    • Berger WE, Milgrom H, Chervinsky P, et al. Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma. Ann Allergy Asthma Immunol 97:672-680, 2006.
    • (2006) Ann Allergy Asthma Immunol , vol.97 , pp. 672-680
    • Berger, W.E.1    Milgrom, H.2    Chervinsky, P.3
  • 25
    • 17744368868 scopus 로고    scopus 로고
    • Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler
    • Bousquet J, D'Urzo A, Herbert J, et al. Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler. Eur Respir J 16:808-816, 2000.
    • (2000) Eur Respir J , vol.16 , pp. 808-816
    • Bousquet, J.1    D'Urzo, A.2    Herbert, J.3
  • 26
    • 33751511781 scopus 로고    scopus 로고
    • A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma
    • Ferguson AC, Van Bever HP, Teper AM, et al. A comparison of the relative growth velocities with budesonide and fluticasone propionate in children with asthma. Respir Med 101:118-129, 2007.
    • (2007) Respir Med , vol.101 , pp. 118-129
    • Ferguson, A.C.1    Van Bever, H.P.2    Teper, A.M.3
  • 27
    • 0033965966 scopus 로고    scopus 로고
    • Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma
    • Skoner DP, Szefler SJ, Welch M, et al. Longitudinal growth in infants and young children treated with budesonide inhalation suspension for persistent asthma. J Allergy Clin Immunol 105:259-268, 2000.
    • (2000) J Allergy Clin Immunol , vol.105 , pp. 259-268
    • Skoner, D.P.1    Szefler, S.J.2    Welch, M.3
  • 28
    • 0033501956 scopus 로고    scopus 로고
    • Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma
    • Scott MB, and Skoner DP. Short-term and long-term safety of budesonide inhalation suspension in infants and young children with persistent asthma. J Allergy Clin Immunol 104:200-209, 1999.
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 200-209
    • Scott, M.B.1    Skoner, D.P.2
  • 29
    • 0034642055 scopus 로고    scopus 로고
    • Long-term treatment with inhaled budesonide on adult height in children with asthma
    • Agertoft L, and Pedersen S. Long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343:1064-1069, 2000.
    • (2000) N Engl J Med , vol.343 , pp. 1064-1069
    • Agertoft, L.1    Pedersen, S.2
  • 30
    • 34547634019 scopus 로고    scopus 로고
    • Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2) - The risk as determined by gold standard adrenal function tests: A systematic review
    • Zollner EW. Hypothalamic-pituitary-adrenal axis suppression in asthmatic children on inhaled corticosteroids (Part 2) - The risk as determined by gold standard adrenal function tests: a systematic review. Pediatr Allergy Immunol 18:469-474, 2007.
    • (2007) Pediatr Allergy Immunol , vol.18 , pp. 469-474
    • Zollner, E.W.1
  • 31
    • 22244470407 scopus 로고    scopus 로고
    • Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects
    • Chrousos GP, Ghaly L, Shedden A, et al. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. Chest 128:70-77, 2005.
    • (2005) Chest , vol.128 , pp. 70-77
    • Chrousos, G.P.1    Ghaly, L.2    Shedden, A.3
  • 32
    • 20944444681 scopus 로고    scopus 로고
    • Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis in adults with mild-to-moderate persistent asthma
    • Lipworth BJ, Kaliner MA, LaForce CF, et al. Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 94:465-472, 2005.
    • (2005) Ann Allergy Asthma Immunol , vol.94 , pp. 465-472
    • Lipworth, B.J.1    Kaliner, M.A.2    LaForce, C.F.3
  • 33
    • 2442589717 scopus 로고    scopus 로고
    • Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary- adrenal-axis function
    • Sheth KK, Cook CK, Philpot EE, et al. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary- adrenal-axis function. Allergy Asthma Proc 25:115-120, 2004.
    • (2004) Allergy Asthma Proc , vol.25 , pp. 115-120
    • Sheth, K.K.1    Cook, C.K.2    Philpot, E.E.3
  • 34
    • 37349038339 scopus 로고    scopus 로고
    • Systemic exposure and urinary Cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma
    • Kim KT, Milgrom H, Yoon YK, et al. Systemic exposure and urinary Cortisol effects of fluticasone propionate formulated with hydrofluoroalkane in 4- to 11-year-olds with asthma. J Clin Pharmacol 48:108-116, 2008.
    • (2008) J Clin Pharmacol , vol.48 , pp. 108-116
    • Kim, K.T.1    Milgrom, H.2    Yoon, Y.K.3
  • 35
    • 33751109992 scopus 로고    scopus 로고
    • Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: A randomized, double-blind, placebo-controlled study
    • Qaqundah PY, Sugerman RW, Ceruti E, et al. Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: A randomized, double-blind, placebo-controlled study. Pediatrics 149:663-670, 2006.
    • (2006) Pediatrics , vol.149 , pp. 663-670
    • Qaqundah, P.Y.1    Sugerman, R.W.2    Ceruti, E.3
  • 36
    • 2542597740 scopus 로고    scopus 로고
    • Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma
    • Bacharier LB, Raissy HH, Wilson L, et al. Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma. Pediatrics 113:1693-1699, 2004.
    • (2004) Pediatrics , vol.113 , pp. 1693-1699
    • Bacharier, L.B.1    Raissy, H.H.2    Wilson, L.3
  • 37
    • 33746853410 scopus 로고    scopus 로고
    • Adrenal function improves in asthmatic children on inhaled steroids: A longitudinal study
    • Priftis KN, Papadimitriou A, Anthracopoulos MB, et al. Adrenal function improves in asthmatic children on inhaled steroids: A longitudinal study. Neuroimmunomodulation 13:56-62, 2006.
    • (2006) Neuroimmunomodulation , vol.13 , pp. 56-62
    • Priftis, K.N.1    Papadimitriou, A.2    Anthracopoulos, M.B.3
  • 38
    • 0042235397 scopus 로고    scopus 로고
    • Potential adverse effects of the inhaled corticosteroids
    • Kelly HW. Potential adverse effects of the inhaled corticosteroids. J Allergy Clin Immunol 112:469-478, 2003.
    • (2003) J Allergy Clin Immunol , vol.112 , pp. 469-478
    • Kelly, H.W.1
  • 40
    • 33645750002 scopus 로고    scopus 로고
    • Risk of cataracts and glaucoma with inhaled steroid use in children
    • Nootheti S, and Bielory L. Risk of cataracts and glaucoma with inhaled steroid use in children. Compr Opthalmol Update 7:31-39, 2006.
    • (2006) Compr Opthalmol Update , vol.7 , pp. 31-39
    • Nootheti, S.1    Bielory, L.2
  • 41
    • 33745964586 scopus 로고    scopus 로고
    • Ocular toxicity of systemic asthma and allergy treatments
    • Bielory L. Ocular toxicity of systemic asthma and allergy treatments. Curr Allergy Asthma Rep 6:299-305, 2006.
    • (2006) Curr Allergy Asthma Rep , vol.6 , pp. 299-305
    • Bielory, L.1
  • 42
    • 0141748410 scopus 로고    scopus 로고
    • A population based case-control study of cataract and inhaled corticosteroids
    • Smeeth L, Boulis M, Hubbard R, and Fletcher AE. A population based case-control study of cataract and inhaled corticosteroids. Br J Opthalmol 87:1247-1251, 2003.
    • (2003) Br J Opthalmol , vol.87 , pp. 1247-1251
    • Smeeth, L.1    Boulis, M.2    Hubbard, R.3    Fletcher, A.E.4
  • 43
    • 0030859363 scopus 로고    scopus 로고
    • Use of inhaled corticosteroids and the risk of cataracts
    • Cumming RG, Mitchell P, and Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 337:8-14, 1997.
    • (1997) N Engl J Med , vol.337 , pp. 8-14
    • Cumming, R.G.1    Mitchell, P.2    Leeder, S.R.3
  • 44
    • 0029078927 scopus 로고
    • Posterior subcapsular cataract and inhaled corticosteroid therapy
    • Abuekteish F, Kirkpatrick JN, and Russell G. Posterior subcapsular cataract and inhaled corticosteroid therapy. Thorax 50:674-676, 1995.
    • (1995) Thorax , vol.50 , pp. 674-676
    • Abuekteish, F.1    Kirkpatrick, J.N.2    Russell, G.3
  • 45
    • 6844265571 scopus 로고    scopus 로고
    • Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma
    • Reed CE, Offord KP, Nelson HS, et al. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. J Allergy Clin Immunol 101:14-23, 1998.
    • (1998) J Allergy Clin Immunol , vol.101 , pp. 14-23
    • Reed, C.E.1    Offord, K.P.2    Nelson, H.S.3
  • 46
    • 0030895038 scopus 로고    scopus 로고
    • Prevalence of cataract in Australia: The Blue Mountains eye study
    • Mitchell P, Cumming RG, Attebo K, and Panchapakesan J. Prevalence of cataract in Australia: The Blue Mountains eye study. Ophthalmology 104:581-588, 1997.
    • (1997) Ophthalmology , vol.104 , pp. 581-588
    • Mitchell, P.1    Cumming, R.G.2    Attebo, K.3    Panchapakesan, J.4
  • 47
    • 0031044736 scopus 로고    scopus 로고
    • Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma
    • Garbe E, LeLorier J, Boivin JF, and Suissa S. Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 277:722-727, 1997.
    • (1997) JAMA , vol.277 , pp. 722-727
    • Garbe, E.1    LeLorier, J.2    Boivin, J.F.3    Suissa, S.4
  • 48
    • 13544276311 scopus 로고    scopus 로고
    • Cataract and ocular hypertension in children on inhaled corticosteroid therapy
    • Behbehani AH, Owayed AF, Hijazi ZM, et al. Cataract and ocular hypertension in children on inhaled corticosteroid therapy. J Pediatr Ophthalmol Strabismus 42:23-27, 2005.
    • (2005) J Pediatr Ophthalmol Strabismus , vol.42 , pp. 23-27
    • Behbehani, A.H.1    Owayed, A.F.2    Hijazi, Z.M.3
  • 49
    • 7344248007 scopus 로고    scopus 로고
    • Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group
    • Verberne AA, Frost C, Duiverman EJ, et al. Addition of salmeterol versus doubling the dose of beclomethasone in children with asthma. The Dutch Asthma Study Group. Am J Respir Crit Care Med 158:213-219, 1998.
    • (1998) Am J Respir Crit Care Med , vol.158 , pp. 213-219
    • Verberne, A.A.1    Frost, C.2    Duiverman, E.J.3
  • 50
    • 0036126690 scopus 로고    scopus 로고
    • Significant variability in response to inhaled corticosteroids for persistent asthma
    • Szefler SJ, Martin RJ, King TS, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 109:410-418, 2002.
    • (2002) J Allergy Clin Immunol , vol.109 , pp. 410-418
    • Szefler, S.J.1    Martin, R.J.2    King, T.S.3
  • 51
    • 0033542041 scopus 로고    scopus 로고
    • Systemic adverse effects of inhaled corticosteroid therapy: A systemic review of meta analysis
    • Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systemic review of meta analysis. Arch Intern Med 159:941-955, 1999.
    • (1999) Arch Intern Med , vol.159 , pp. 941-955
    • Lipworth, B.J.1
  • 52
    • 0036159288 scopus 로고    scopus 로고
    • Balancing safety and efficacy in pediatric asthma management
    • Skoner DP. Balancing safety and efficacy in pediatric asthma management. Pediatrics 109:381-392, 2002.
    • (2002) Pediatrics , vol.109 , pp. 381-392
    • Skoner, D.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.